Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
The Patient-Clinician Connection in Managing CKD-aP
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Improving Sleep and Mental Health in Patients with CKD-aP
Leonie Kraft, MD
Kappa-Opioid Settings: Real-World Evidence Insights
Emilio Sanchez, MD, PhD
Elevating CKD-aP Care: New Frontier
CKD-aP: Beyond the Surface
Potassium Binders: Safety Comes First!
Javed Butler, MD, MPH, MBA
Potassium Binders in Practice: Clinical Trial Evidence
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Jürgen Floege, MD
Loreto Gesualdo, MD, FERA
KALMing the Itch: Improving QoL in Patients with CKD-aP
Joel Topf, MD
Kieran McCafferty, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.